AD-2072

N/A

Report date: 2024/07/05 20:00:49

Base Information

Drug NameAD-2072

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHyperlipidemiasHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesYuhan Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAddpharma Inc

Active IndicationsN/A

Inactive IndicationsHyperlipidemiasHypertension

ATC CodeN/A